M4MM

Cronos Group Inc Reports Q2 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

Legal Status of Cannabis in Europe

LOS ANGELES- A growing number of European countries now permit the use, cultivation or sale of cannabis under regulated conditions, driven by evolving public policy and emerging economic opportunity. Germany legalized limited recreational use on ...

Cronos Group Inc Reports Q2 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

Trulieve Reports Q2 2024 Financial Results

LOS ANGELES- Trulieve announced its financial results for the second quarter ending June 30, 2024. The results, reported in U.S. dollars and following U.S. Generally Accepted Accounting Principles (GAAP), reflect continued growth and operational expansion. ...

Ohio to Launch Recreational Cannabis Sales 

LOS ANGELES- Ohio will commence recreational cannabis sales early next week, possibly as soon as Tuesday, August 6, following the issuance of the first necessary licenses on Monday. Jamie Crawford, Public Information Officer for Ohio’s ...

Tilray Expands Medical Cannabis Portfolio in Portugal

LOS ANGELES- Tilray Brands, Inc.  has announced a new achievement in its European medical cannabis operations. The company received approval for its new product, Tilray Solução Oral THC10, in Portugal. This follows earlier approvals for ...

Curaleaf Earnings Estimates Lowered

LOS ANGELES- Analysts at Atb Cap Markets have revised their Q2 2024 earnings estimates for Curaleaf Holdings, Inc. now forecasting a loss of $0.04 per share, down from a previous estimate of $0.03 per share. ...

Subscribe To Our Newsletter